关键词: 肝细胞性肝癌, 多模式治疗, 解剖性肝切除, 非解剖性肝切除, 肝移植

Abstract:

Consensus and controversy on multimodal therapy for hepatocellular carcinoma        LI Xiang-cheng，LI Chang-xian，ZHANG Jia-wei，et al. Liver Transplantation Center，the First Affiliated Hospital of Nanjing Medical University，Nanjing 210029，China
Corresponding auhor：LI Xiang-cheng，E-mail：drxcli@njmu.edu.cn
Abstract    With the development of medical technology，the treatment of hepatocellular carcinoma (HCC) has developed into a multidisciplinary and multimodal treatment model. At present，there are many treatments for HCC，including surgical resection, liver transplantation，ablation，transarterial chemoembolization，radioembolization，molecular targeted therapy, chemotherapy，immunotherapy and so on. To improve the overall curative effect of HCC，the treatment plan should be formulated according to different individuals by using multidisciplinary advantages. At present，surgery is still the best radical treatment for the patients with resectable HCC. Comprehensive treatment can be an important supplement to surgical treatment, which increase the chance of surgical resection and reduce postoperative recurrence and metastasis，and provide a good treatment opportunity for advanced HCC patients，and prolong the survival of patients.

Key words: hepatocellular carcinoma, multimodal treatment, anatomic resection, non-natomic resection, liver transplantation